These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Poor correlation between acute phase reactants and intestinal involvement in patients with onset of Crohn's disease under treatment with an interleukin-6 inhibitor due to seronegative arthropathy. Zacarías Martínez L; Mateo Soria L; Mañosa Círia M; Clos Parals A; Cabré Gelada E; Domènech Morral E Gastroenterol Hepatol; 2016 Dec; 39(10):670-672. PubMed ID: 26589538 [No Abstract] [Full Text] [Related]
17. What is the role and significance of serum and stool biomarkers in the diagnosis of IBD? Palmon R; Brown SJ; Abreu MT Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S187-9. PubMed ID: 18816678 [TBL] [Abstract][Full Text] [Related]
18. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin. Zubin G; Peter L Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564 [TBL] [Abstract][Full Text] [Related]
19. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease. Boschetti G; Garnero P; Moussata D; Cuerq C; Préaudat C; Duclaux-Loras R; Mialon A; Drai J; Flourié B; Nancey S Inflamm Bowel Dis; 2015 Feb; 21(2):331-6. PubMed ID: 25625487 [TBL] [Abstract][Full Text] [Related]
20. [The diagnosis of IBD must have a wide foundation]. Grip O; Halfvarson J; Carlson M; Sternby B Lakartidningen; 2009 Nov 4-12; 106(45):2984-6. PubMed ID: 19998823 [No Abstract] [Full Text] [Related] [Next] [New Search]